Language: BG BG
← Back to results
Recruiting Phase 4 2026-526040-13-00

Single-Dose Study in Healthy Participants to Compare the Bioavailability of One Film-Coated Mini-Tablet of Indapamide SR 1.5 mg versus One Film-Coated Tablet of Indapamide IR 2.5 mg Under Fasting Conditions, and to Compare the Bioavailability of One Film-Coated Mini-Tablet of Indapamide SR 1.5 mg Under Fasting versus Fed Conditions.

Phase 4 – monitoring after market approval
Conditions: No medical condition.

Sponsor: Institut De Recherches Internationales Servier IRIS

trial.available_in: БГ
Overview
Trial status: Authorised
Who can participate
Age group: 18-64 years Gender: Female, Male Target enrollment: 24 participants
Locations 1
Portugal (1)
Technical details
Status
Recruiting
Phase
Phase 4
Study type
INTERVENTIONAL
Sex
Male and female
Minimum age
18 Years
Maximum age
64 Years
Healthy volunteers
No
Start date
22.04.2026
Registry ID
2026-526040-13-00
Source
euclinicaltrials.eu
trial.inquiry_btn

Information is automatically extracted from ClinicalTrials.gov. Consult your doctor before taking action.